◆ 会议时间：2023年4月25日至28日
◆ 会议地点：法国 巴黎
◆ 会议简介：
2023年全球肝炎峰会(GHS2023)-第18届国际病毒性肝炎与肝病研讨会将于2023年4月25日至28日在法国巴黎举行。作为ISVHLD的传统，全球肝炎峰会将汇集来自世界各地的顶级临床医生和研究人员。为期四天密集而又充满活力的科学会议，将为当前肝炎发展各方面的所有参与者提供了众多学习机会。ISVHLD将邀请100多位国际知名的演讲者，主持有关病毒性肝炎和肝病基础、临床和公共卫生科学领域的全体会议和平行科学会议，他们不仅在诊断、治疗等方面有丰富的知识和经验，而且在病毒性肝炎、HCC、NASH等肝病的治疗方面也有着丰富的经验；世界领先的优秀科学计划委员会将制定最高质量的科学教育计划，提供突破性的摘要、科学海报和电子海报、行业研讨会、招待会、社交活动、展览等等，预计将有1500余名来自世界各地的一流临床医生和研究人员参会。未经许可禁止复制摘录本站任何内容-国际医学会议网(lingyuint.com)
Global Hepatitis Summit (GHS 2023)
18th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)
Date: April 25-28, 2023
Venue: Pullman Paris Montparnasse, Paris, France
摘要征文投稿：
Abstract submission deadline: December 6, 2022
SUBMIT YOUR ABSTRACT HERE
Abstract formatting guidelines
Please adhere to the following formatting guidelines when submitting your abstracts for GHS 2023. Abstracts that are not correctly formatted will not be reviewed.
- The abstract title should not exceed 300 characters
- The abstracts should not exceed 3,000 characters
- Each abstract is allowed to include a maximum of three (3) caption (figure or table) but this is not a requirement. Minimize the use of charts and graphics as this detail is not used to evaluate the merit of your abstract
- There is no restriction on your abstract structure, but we recommended the following:
- Title
- Background
- Purpose
- Method(s)
- Result(s)
- Conclusion(s)
Notification of acceptance
Presenting authors will be notified of their acceptance status on or before February 1, 2023. Presenting authors must inform any co-author(s) of acceptance. The organizing committee reserves the right to accept or decline any submissions and to select the presentation format (oral or poster).
Disclosure of conflicts of interest
The presenting authors of abstracts selected for oral presentation will be required to complete and submit a Disclosure of Conflicts of Interest form after they are invited to present. Disclosures are due on or before the RSVP deadline.
Disclaimer regarding the submission of abstracts
The Conference Organizers will not be held responsible for abstract submissions not received via the website or for submission errors caused by internet service outages, hardware or software delays, power outages or unforeseen events.
Dear Friends and Colleagues,
It is with great pleasure that we invite you to join us in Paris, France April 25 – 28, 2023 for the 18th Global Hepatitis Summit (GHS 2023), a 50-year legacy of the International Symposium on Viral Hepatitis and Liver Disease (ISVHLD).
It is with renewed vigor and excitement that GHS 2023 will be delivered as a hybrid meeting, offering to meet in-person in the beautiful capital city of Paris, France, or alternatively from the comfort of your office/home’s virtual setting.
The GHS 2023 faculty has been carefully selected to achieve the global diversity and gender balance that is reflective of our scientific community today. 2023 will feature a unique interdisciplinary Summit designed to share the latest developments in all aspects of liver diseases, including viral hepatitis, non-alcoholic fatty liver disease, hepatocellular carcinoma and so on. It will encompass the continuum of research from basic science to clinical research and public health applications.
GHS 2023 will be as much a networking event as a cutting-edge research conference, featuring dedicated tracks for health practitioners and inspiring workshops for those working in the liver and hepatitis space, where renown speakers will highlight the most exciting recent results in the field and provide perspectives for research and patient management.
Multidisciplinary focus for all areas of interest will include basic science, translational research, development of novel diagnostic tools and therapies, and approaches to control and eliminate liver diseases as public health threats.
It will be our pleasure to welcome you to Paris for this historic scientific meeting.
With kind regards,
Prof. Jean-Michel Pawlotsky, MD, PhD
Co-Chair, GHS 2023
- French National Reference Center for Viral Hepatitis B, C and delta,
- Chief, Department of Biology
- Head, Department of Virology, Bacteriology-Hygiene, and Mycology-Parasitology
- Head, Research Team “Pathophysiology and Therapy of Chronic Viral Hepatitis and Related Cancers” INSERM
- Henri Mondor Hospital University of Paris
Prof. Fabien Zoulim, MD, PhD
Co-Chair, GHS 2023
- Head, Hepatology Department, Lyon Civil Hospital
- Head of Viral Hepatitis Team, INSERM
- Cancer Research Center of Lyon
- Professor of Medicine, Lyon University
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
